Showing results (51-60 of 458) with videos related to
Sort By:
Pageof 46
Acta Oncologica (Stockholm, Sweden)|September 27, 2007
A Phase I trial of weekly docetaxel and topotecan for solid tumorsWan Teck Lim, Maria Q Baggstrom, William Read, et al.NPJ Precision Oncology|October 12, 2019
Liquid biopsy: one cell at a timeSu Bin Lim, Wen Di Lee, Jyothsna Vasudevan, et al.Biomedicines|February 25, 2023
Circulating Biomarkers for Prediction of Immunotherapy Response in NSCLCKah Yee Goh, Terence You De Cheng, Su Chin Tham, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 15, 2004
Simple and rapid docetaxel assay in plasma by protein precipitation and high-performance liquid chromatography-tandem mass spectrometryWeiying Hou, James W Watters, Howard L McLeodClinical Advances in Hematology & Oncology : H&O|October 15, 2005
Using genetic variation to optimize cancer chemotherapyHoward L McLeod, Chris Papageorgio, James W WattersTrends in Molecular Medicine|February 2, 2013
Current pharmacogenomic studies on hERG potassium channelsFa-Zhong He, Howard L McLeod, Wei ZhangAnnual Review of Pharmacology and Toxicology|January 9, 2010
Economic opportunities and challenges for pharmacogenomicsPatricia A Deverka, John Vernon, Howard L McLeodPharmacogenomics|August 5, 2006
Pharmacogenetics of alkylator-associated acute myeloid leukemiaEric Knoche, Howard L McLeod, Timothy A GraubertJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 29, 2013
Clinically relevant cancer biomarkers and pharmacogenetic assaysJai N Patel, Katherine Mandock, Howard L McLeodBritish Journal of Clinical Pharmacology|May 25, 2013
Implications of genome-wide association studies in cancer therapeuticsJai N Patel, Howard L McLeod, Federico InnocentiPageof 46